Primary Progressive Aphasia Clinical Trial
— SCED-APPvsOfficial title:
Evaluation of the Effect of a Semantic Rehabilitation in Patients in the Mild to Moderate Stage of Primary Progressive Semantic Aphasia : a SCED Study
This project aims to measure the effect of a semantic rehabilitation protocol for patients with primary progressive semantic aphasia and using the SCED methodology.
Status | Recruiting |
Enrollment | 15 |
Est. completion date | September 2025 |
Est. primary completion date | September 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility | Inclusion Criteria: - Have a diagnosis of primary progressive semantic aphasia according to the criteria of Gorno-Tempini et al (2011) (Appendix A) - Being in the mild to moderate stage of dementia (MMSE score between 10 and 28) (Crum et al., 1993; Derouesné et al., 1999) - Common French - Being affiliated to a social security scheme - Being over the age of 18 years old Exclusion Criteria: - Have significant uncorrected visual and/or hearing impairment - Have a history of brain injuries, major head trauma - Have untreated psychiatric disorders - Have significant motor and/or comprehension problems that make it impossible to take part in the study - Chronical use of drugs and/or alcohol - Under guardians or curators - Severe depression (Beck's depression scale score > 9) (Beck & al., 1961) |
Country | Name | City | State |
---|---|---|---|
France | CHU Toulouse | Toulouse |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Toulouse |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Performance in speaking | To evaluate speaking accuracy, the study team will assess the number of correct items recovered by the patient when performing a specific naming task before the rehabilitation.
The naming task is a selection of 80 items developped by Coustaut in 2019 in its MetaLex protocol. |
Baseline (before phase A) | |
Primary | Performance in speaking | To evaluate speaking response time, the study team will assess the rate at which items are recovered by the patient when performing a specific naming task before the rehabilitation.
The naming task is a selection of 80 items developped by Coustaut in 2019 in its MetaLex protocol. |
Baseline (before phase A) | |
Primary | Performance in speaking | To evaluate speaking accuracy, the study team will assess the number of correct items repeated by the patient when performing a specific naming task after the rehabilitation.
The naming task is a selection of 80 items developped by Coustaut in 2019 in its MetaLex protocol. |
immediately after the intervention (after phase B) | |
Primary | Performance in speaking | To evaluate speaking response time, the study team will assess the rate at which items are recovered by the patient when performing a specific naming task after rehabilitation.
The naming task is a selection of 80 items developped by Coustaut in 2019 in its MetaLex protocol. |
immediately after the intervention (after phase B) | |
Secondary | Maintenance of the performance in speaking | Number of correct items recovered by the patient when performing a specific naming task 1 month after the end of the intervention.
The naming task is a selection of 80 items developped by Coustaut in 2019 in its MetaLex protocol. This will be compared to the number of items correctly recovered at the end of the rehabilitation (corresponding to outcome 3 here). |
1 month after the end of the intervention (after phase B) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT04290988 -
Circuitry Assessment and Reinforcement Training Effects on Recovery
|
N/A | |
Completed |
NCT04045990 -
Network Modulation in Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05443633 -
Enhancing Language Function in Aphasia
|
N/A | |
Completed |
NCT05860647 -
Transmagnetic Stimulation Pilot in Primary Progressive Aphasia
|
N/A | |
Recruiting |
NCT03887481 -
Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA
|
N/A | |
Completed |
NCT03728582 -
Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy
|
N/A | |
Completed |
NCT01465360 -
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
|
N/A | |
Completed |
NCT02541097 -
Preventing Language Decline in Dementia
|
N/A | |
Recruiting |
NCT00537004 -
Language in Primary Progressive Aphasia
|
||
Recruiting |
NCT05741853 -
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
|
N/A | |
Active, not recruiting |
NCT05742698 -
Nabilone for Agitation in Frontotemporal Dementia
|
Phase 2 | |
Completed |
NCT02439853 -
Communication Bridge Speech Therapy Research Study
|
N/A | |
Completed |
NCT01623284 -
PiB PET Scanning in Speech and Language Based Dementias
|
Phase 1 | |
Completed |
NCT04726527 -
Clinical Evaluation of Florbetapir in Primary Progressive Aphasia
|
||
Completed |
NCT03076671 -
More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
|
N/A | |
Completed |
NCT05537688 -
Identification of Graphic Markers of Neurocognitive Disorders (MG)
|
||
Completed |
NCT05525377 -
Better Living With Non-memory-led Dementia
|
N/A | |
Completed |
NCT02928848 -
Transcranial Direct Current Stimulation for Primary Progressive Aphasia
|
N/A | |
Completed |
NCT04939818 -
Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders
|
||
Enrolling by invitation |
NCT05368350 -
Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation
|
Early Phase 1 |